# Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas

> **NCT04224064** · NA · RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 158 (estimated)

## Conditions studied

- Liposarcoma
- Atypical Lipomatous Tumor

## Interventions

- **DIAGNOSTIC_TEST:** Blood sampling

## Key facts

- **NCT ID:** NCT04224064
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-08-26
- **Primary completion:** 2027-12
- **Final completion:** 2029-12
- **Target enrollment:** 158 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224064, "Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04224064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*